Genomics of MRSA eradication
Background  Methicillin-resistant Staphylococcus aureus (MRSA) colonization increases the risk of infection. Response to decolonization treatment is highly variable and determinants for successful decolonization or failure of eradication treatment are largely unknown. Insight into genetic predictors of eradication failure is potentially useful in clinical practice. Objectives The aim of this study was to explore genetic characteristics that are associated with MRSA decolonization failure. Methods This cohort study was performed in a tertiary care hospital in the Netherlands. Patients with =1 positive MRSA culture from any site and with available whole genome sequencing data of the MRSA isolate between 2017-2022 were included. Lineages, resistance and virulence factors were stratified by MRSA decolonization outcome. Results  In total, 56 patients were included: 12/56 (21%) with treatment failure and 44/56 (79%) with successful decolonization (with or without preceding treatment). A significant association was found between ciprofloxacin-resistant lineages and failure of eradication (OR 4.20, 95%CI 1.11-15.96, p=0.04). Furthermore, livestock-associated MRSA and the major community-associated MRSA lineages ST6-t304 and ST8-t008 were associated with successful eradication treatment or spontaneous clearance. Conclusions In conclusion, this explorative study showed a higher eradication failure rate in complicated MRSA carriers with ciprofloxacin-resistant MRSA lineages, which are predominantly healthcare-associated. Further studies are warranted to confirm the higher eradication failure risk of ciprofloxacin-resistant lineages, and identify the underlying mechanisms.